We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$445M
AUM Growth
+$6.22M
Cap. Flow
+$4.93M
Cap. Flow %
1.11%
Top 10 Hldgs %
17.39%
Holding
285
New
23
Increased
106
Reduced
62
Closed
22

Top Buys

Rank Stock Value
1
HON icon
Honeywell
HON
+$2.81M
2
RTX icon
RTX Corp
RTX
+$2.68M
3
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$1.79M
4
PH icon
Parker-Hannifin
PH
+$1.6M
5
KLAC icon
KLA
KLAC
+$1.21M

Sector Composition

Rank Sector Weight
1 Industrials 17.84%
2 Healthcare 15.87%
3 Technology 15.47%
4 Materials 7.53%
5 Financials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LJPC
26
DELISTED
La Jolla Pharmaceutical Company
LJPC
$4.57M 1.03%
156,562
-11,263
-7% -$348K
CRS icon
27
Carpenter Technology
CRS
$27.7B
$4.55M 1.02%
86,561
+1,598
+2% +$86.4K
FSS icon
28
Federal Signal
FSS
$7.11B
$4.53M 1.02%
194,537
+105
+0.1% +$2.44K
LECO icon
29
Lincoln Electric
LECO
$13.8B
$4.24M 0.95%
48,260
+1,281
+3% +$114K
INGR icon
30
Ingredion
INGR
$6.47B
$4.22M 0.95%
38,090
-606
-2% -$71.3K
BALL icon
31
Ball Corp
BALL
$16.7B
$3.94M 0.88%
110,697
-1,652
-1% -$63.3K
BERY
32
DELISTED
Berry Global Group, Inc.
BERY
$3.5M 0.79%
83,040
+4
+0% +$186
FBIN icon
33
Fortune Brands Innovations
FBIN
$6.14B
$3.46M 0.78%
75,301
-1,878
-2% -$91.1K
AKBA icon
34
Akebia Therapeutics
AKBA
$359M
$3.41M 0.77%
341,489
+27,088
+9% +$271K
CSCO icon
35
Cisco
CSCO
$441B
$3.31M 0.74%
76,801
-3,604
-4% -$157K
PFE icon
36
Pfizer
PFE
$143B
$3.3M 0.74%
95,915
-5,280
-5% -$180K
PX
37
DELISTED
Praxair Inc
PX
$3M 0.67%
18,969
-133
-0.7% -$20.5K
HON icon
38
Honeywell
HON
$71.3B
$2.75M 0.62%
+21,094
New +$2.81M
RTX icon
39
RTX Corp
RTX
$261B
$2.69M 0.6%
+34,165
New +$2.68M
IBM icon
40
IBM
IBM
$200B
$2.65M 0.59%
19,812
-783
-4% -$109K
TFC icon
41
Truist Financial
TFC
$65.4B
$2.47M 0.55%
48,914
-1,656
-3% -$88K
EXC icon
42
Exelon
EXC
$47.3B
$2.45M 0.55%
80,691
-12,412
-13% -$355K
CNA icon
43
CNA Financial
CNA
$14.1B
$2.45M 0.55%
53,585
-2,435
-4% -$118K
VZ icon
44
Verizon
VZ
$182B
$2.43M 0.55%
48,356
-8,405
-15% -$407K
PAYX icon
45
Paychex
PAYX
$40.7B
$2.32M 0.52%
33,880
-822
-2% -$53K
SLB icon
46
SLB Ltd
SLB
$70.3B
$2.31M 0.52%
34,468
-1,083
-3% -$74.4K
INTC icon
47
Intel
INTC
$478B
$2.26M 0.51%
45,430
-7,982
-15% -$424K
WMT icon
48
Walmart Inc
WMT
$909B
$2.26M 0.51%
79,017
-7,053
-8% -$201K
BA icon
49
Boeing
BA
$169B
$2.25M 0.51%
6,702
-170
-2% -$58.5K
CME icon
50
CME Group
CME
$88.5B
$2.2M 0.49%
13,434
-523
-4% -$85.4K

Similar funds

Stanley-Laman Group's Q2 2018 Portfolio in Review

As of Q2 2018, Stanley-Laman Group held 285 positions worth $445M, up 1.4% from $439M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stanley-Laman Group's Q2 2018 filing shows 23 new, 106 increased, 62 reduced and 22 closed positions. Its largest new stake was Honeywell: 21,094 shares worth $2.75M. The largest sale was KapStone Paper and Pack Corp., an estimated $4.63M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • Stanley-Laman Group's largest Q2 2018 buy was Honeywell: 21,094 shares worth $2.75M.
  • Stanley-Laman Group added most to Neurocrine Biosciences in Q2 2018, an estimated $960K increase.
  • Stanley-Laman Group's biggest Q2 2018 reduction was Qualys, cutting an estimated $1.16M.
  • Stanley-Laman Group fully exited KapStone Paper and Pack Corp. in Q2 2018, selling an estimated $4.63M.
  • Stanley-Laman Group's ten largest holdings make up 17% of its $445M portfolio in Q2 2018.
  • Stanley-Laman Group opened 23 new positions and closed 22 in Q2 2018.
  • Stanley-Laman Group's portfolio value rose 1.4% quarter-over-quarter to $445M.

Based on Stanley-Laman Group's 13F filing for Q2 2018, filed 9 Aug 2018.